• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author's Reply: "From Data to practice: The necessity of optimizing ustekinumab treatment strategies".

作者信息

Huang Zhaopeng, Lin Lang, Chao Kang, Tang Jian

机构信息

Department of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, No.26 Yuancun Road II, Tianhe district, Guangzhou 510000, PR China; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China; Center for Clinical Research, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China.

Department of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, No.26 Yuancun Road II, Tianhe district, Guangzhou 510000, PR China; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China; Center for Clinical Research, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China.

出版信息

Dig Liver Dis. 2025 Jun;57(6):1336-1337. doi: 10.1016/j.dld.2025.03.020. Epub 2025 Apr 5.

DOI:10.1016/j.dld.2025.03.020
PMID:40189423
Abstract
摘要

相似文献

1
Author's Reply: "From Data to practice: The necessity of optimizing ustekinumab treatment strategies".
Dig Liver Dis. 2025 Jun;57(6):1336-1337. doi: 10.1016/j.dld.2025.03.020. Epub 2025 Apr 5.
2
Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval? Author's reply.信函：对于应答丧失的患者，乌司奴单抗剂量强化——我们应该在缩短给药间隔之前重新诱导吗？作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(3):565-566. doi: 10.1111/apt.15892.
3
Author's reply: ``Optimization of Ustekinumab dosing in Crohn's disease: Addressing variability in treatment strategies and dosing evaluation''.作者回复：“优化乌司奴单抗在克罗恩病中的给药：解决治疗策略和剂量评估中的变异性”
Dig Liver Dis. 2025 Jun;57(6):1347. doi: 10.1016/j.dld.2025.03.028. Epub 2025 Apr 12.
4
Letter: optimising response to ustekinumab therapy for patients with Crohn's disease-author's reply.信件：优化克罗恩病患者对优特克单抗治疗的反应——作者回复
Aliment Pharmacol Ther. 2020 Sep;52(5):907. doi: 10.1111/apt.15974.
5
Author's Reply: "Ustekinumab and vedolizumab: A step forward in managing complex perianal fistulas in Crohn's disease".作者回复：“优特克单抗和维多珠单抗：克罗恩病复杂性肛周瘘管治疗的一大进步”
Dig Liver Dis. 2025 Jun;57(6):1340-1341. doi: 10.1016/j.dld.2025.04.005. Epub 2025 Apr 29.
6
From data to practice: The necessity of optimizing ustekinumab treatment strategies.从数据到实践：优化优特克单抗治疗策略的必要性。
Dig Liver Dis. 2025 Jun;57(6):1335. doi: 10.1016/j.dld.2025.02.022. Epub 2025 Mar 9.
7
Optimizing ICU weaning: globalizing personalized weaning strategies-author's reply.优化重症监护病房撤机：将个性化撤机策略全球化——作者回复
Intensive Care Med. 2025 Feb;51(2):448-449. doi: 10.1007/s00134-024-07769-x. Epub 2025 Jan 16.
8
Optimizing ICU antifungal therapy: overcoming pharmacokinetic limitations with combination strategies-author's reply.优化重症监护病房抗真菌治疗：通过联合策略克服药代动力学限制——作者回复
Intensive Care Med. 2025 Apr;51(4):813-814. doi: 10.1007/s00134-025-07872-7. Epub 2025 Mar 31.
9
Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit. Author's reply.重症监护病房中优化肺孢子菌肺炎治疗的挑战。作者回复。
Intensive Care Med. 2024 Oct;50(10):1721-1722. doi: 10.1007/s00134-024-07592-4. Epub 2024 Aug 15.
10
Optimizing non-intubated respiratory support in COVID-19: evaluating the impact of bundle of care strategy on awake prone positioning tolerance. Author's reply.优化新型冠状病毒肺炎非插管呼吸支持：评估护理集束策略对清醒俯卧位耐受性的影响。作者回复
Intensive Care Med. 2025 May;51(5):984-985. doi: 10.1007/s00134-025-07904-2. Epub 2025 Apr 29.